George Kelly Martin, Director at TriSalus Life Sciences, Inc. (TLSI), sold 9 shares at $5.50 ($50) on 2024-08-28, disclosed to the SEC on 2024-09-10.
Open-market sale of $50 TLSI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.